Hydra Biosciences Company
Hydra Biosciences develops novel drugs to treat pain, inflammation, cardiovascular and other diseases using ion channels.
.png)
.jpg)
.png)
Technology:
Cancer
Industry:
PharmTech
Headquarters:
Cambridge, Massachusetts, United States
Founded Date:
1/1/2001
Employees Number:
11-50
Funding Status:
Late Stage Venture
Total Funding:
94877500
Estimated Revenue:
$1M to $10M
Last Funding Type:
Series E
Register and Claim Ownership